|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.330 TRY | -3.68% |
|
-12.53% | -7.91% |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenues | 309.95Cr | 521.58Cr | 1.11TCr | 2.34TCr | 1.73TCr |
Total Revenues | 309.95Cr | 521.58Cr | 1.11TCr | 2.34TCr | 1.73TCr |
Cost of Goods Sold, Total | 263.84Cr | 407.78Cr | 973.34Cr | 2.14TCr | 1.45TCr |
Gross Profit | 46Cr | 113.8Cr | 133.57Cr | 200.37Cr | 283.93Cr |
Selling General & Admin Expenses, Total | 27Cr | 73Cr | 121.22Cr | 146.39Cr | 174.89Cr |
Other Operating Expenses | -55.34L | -71.97L | -3Cr | -43Cr | -12Cr |
Other Operating Expenses, Total | 26Cr | 73Cr | 118.22Cr | 103.7Cr | 163.2Cr |
Operating Income | 20Cr | 41Cr | 15Cr | 97Cr | 120.74Cr |
Interest Expense, Total | -1.94Cr | -1.82Cr | -14Cr | -144.82Cr | -11Cr |
Interest And Investment Income | 13.34L | 47.45L | 15.32L | 50Cr | 16Cr |
Net Interest Expenses | -1.81Cr | -1.35Cr | -14Cr | -94Cr | 4.77Cr |
Currency Exchange Gains (Loss) | -2.27Cr | -26Cr | 9.35Cr | 84Cr | 45Cr |
Other Non Operating Income (Expenses) | -8L | -50.75L | -2.5Cr | 77Cr | -153.31Cr |
EBT, Excl. Unusual Items | 16Cr | 13Cr | 8.04Cr | 163.86Cr | 17Cr |
Gain (Loss) On Sale Of Investments | - | - | - | - | -34Cr |
Insurance Settlements | 5L | - | 7L | 7L | 3.33Cr |
Legal Settlements | 4L | -13.98L | -29.42L | 93.82L | 3.62Cr |
EBT, Incl. Unusual Items | 16Cr | 13Cr | 7.82Cr | 164.87Cr | -9.92Cr |
Income Tax Expense | 23.34L | 61.45L | -3.14Cr | 37Cr | -41Cr |
Earnings From Continuing Operations | 16Cr | 13Cr | 11Cr | 127.89Cr | 31Cr |
Net Income to Company | 16Cr | 13Cr | 11Cr | 127.89Cr | 31Cr |
Net Income - (IS) | 16Cr | 13Cr | 11Cr | 127.89Cr | 31Cr |
Net Income to Common Incl Extra Items | 16Cr | 13Cr | 11Cr | 127.89Cr | 31Cr |
Net Income to Common Excl. Extra Items | 16Cr | 13Cr | 11Cr | 127.89Cr | 31Cr |
Per Share Items | |||||
Net EPS - Basic | - | - | 0.04 | 0.52 | 0.11 |
Basic EPS - Continuing Operations | - | - | 0.04 | 0.52 | 0.11 |
Basic Weighted Average Shares Outstanding | - | - | 244.3Cr | 244.3Cr | 287.65Cr |
Net EPS - Diluted | - | - | 0.04 | 0.52 | 0.11 |
Diluted EPS - Continuing Operations | - | - | 0.04 | 0.52 | 0.11 |
Diluted Weighted Average Shares Outstanding | - | - | 244.3Cr | 244.3Cr | 287.65Cr |
Normalized Basic EPS | - | - | 0.02 | 0.42 | 0.04 |
Normalized Diluted EPS | - | - | 0.02 | 0.42 | 0.04 |
Dividend Per Share | - | - | - | 0.11 | 0.01 |
Payout Ratio | 2.9 | - | 77.77 | - | 99.86 |
Supplemental Items | |||||
EBITDA | 22Cr | 44Cr | 19Cr | 119.1Cr | 156.93Cr |
EBITA | 20Cr | 41Cr | 15Cr | 97Cr | 120.75Cr |
EBIT | 20Cr | 41Cr | 15Cr | 97Cr | 120.74Cr |
Effective Tax Rate - (Ratio) | 1.48 | 4.63 | -40.16 | 22.43 | 409.3 |
Total Current Taxes | 2L | 3L | 3L | 13Cr | 6.28Cr |
Total Deferred Taxes | 20.98L | 58.01L | -3.17Cr | 24Cr | -47Cr |
Normalized Net Income | 9.78Cr | 8.38Cr | 5.03Cr | 102.41Cr | 11Cr |
Supplemental Operating Expense Items | |||||
Advertising Expense | - | - | - | 77.98L | 3.67Cr |
Marketing Expenses | 23Cr | 67Cr | 115.42Cr | 136.56Cr | 147.27Cr |
Selling and Marketing Expenses | 23Cr | 67Cr | 115.42Cr | 137.34Cr | 150.94Cr |
General and Administrative Expenses | 3.84Cr | 5.81Cr | 5.8Cr | 9.05Cr | 24Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















